What is MedAware?
MedAware operates at the intersection of artificial intelligence and clinical safety, providing a robust platform designed to identify and mitigate medication-related risks throughout the patient journey. By leveraging advanced data analytics, the company offers a critical safety layer that integrates with existing electronic health records and medical devices. This technological architecture enables healthcare providers to enhance decision support, optimize operational outcomes, and significantly reduce the incidence of adverse drug events. As hospitals and clinics face increasing pressure to improve patient safety metrics, MedAware's solution serves as a vital tool for modernizing clinical workflows and ensuring high-fidelity care delivery across diverse medical environments.
How much funding has MedAware raised?
MedAware has raised a total of $9.3M across 3 funding rounds:
Grant
$25K
Other Financing Round
$1.3M
Series A
$8M
Grant (2015): $25K with participation from MedTech Innovator companies
Other Financing Round (2016): $1.3M led by OurCrowd and Winton Ventures
Series A (2017): $8M supported by OurCrowd, Becton, Dickinson and Company, and Gefen Capital
Key Investors in MedAware
OurCrowd
An Israel-based investment platform that facilitates participation for accredited investors and institutions in early-stage startups and venture funds.
Becton, Dickinson and Company
A global medical technology leader focused on developing innovative diagnostic systems, laboratory equipment, and solutions for patient safety and drug delivery.
Gefen Capital
A venture capital firm that employs a flexible, long-term investment strategy to support US-facing companies with strong technological differentiation.
What's next for MedAware?
With the recent infusion of capital, MedAware is well-positioned to accelerate its enterprise-level expansion and deepen its technological moat. The company's strategic roadmap likely involves scaling its integration capabilities to support larger health systems and expanding its predictive modeling features to cover a broader spectrum of clinical risks. By leveraging the expertise of its diverse investor base, MedAware is poised to transition from a specialized safety tool to an essential component of the digital health ecosystem, focusing on long-term value creation through improved patient outcomes and reduced liability for healthcare institutions.
See full MedAware company page
